Get started
Author

Núria Padullés Zamora

Observed names: N Padulles Zamora, N Padulles-Zamora, N Padullés Zamora, N Padullés-Zamora, N. Padullés, N. Padullés Zamora, N. Padullés-Zamora, NURIA PADULLES ZAMORA, Nuria Padulles, Nuria Padulles Zamora, Nuria Padullès, Nuria Padullés Zamora, Nuria Padullés-Zamora, NÚRIA PADULLÉS ZAMORA, Núria Padullès, Núria Padullés, Núria Padullés-Zamora, Padullés Zamora,Núria, Padullés-Zamora,Núria, Padullés Zamora, N, Padullés Zamora, Núria, Padullés-Zamora, Núria
ORCID: 0000-0002-8783-3042
Observed ORCID: 0000-0002-8783-3042
OpenAlex ID: A5030045485
Beneficial effect of corticosteroids in preventing mortality in patients receiving tocilizumab to treat severe COVID-19 illness
2020 · Manuel Rubio-Rivas, Mar Ronda, et al. · International Journal of Infectious Diseases · 47
PDF
Best Practice for Therapeutic Drug Monitoring of Infliximab: Position Statement from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology
2024 · Dahham Alsoud, Dirk Jan A. R. Moes, et al. · Therapeutic Drug Monitoring · 26
PDF
Bayes‐based dosing of infliximab in inflammatory bowel diseases: Short‐term efficacy
2020 · Eugènia Santacana Juncosa, Lorena Rodríguez‐Alonso, et al. · British Journal of Clinical Pharmacology · 22
PDF
Pragmatic, open-label, single-center, randomized, phase II clinical trial to evaluate the efficacy and safety of methylprednisolone pulses and tacrolimus in patients with severe pneumonia secondary to COVID-19: The TACROVID trial protocol
2021 · X. Solanich, A. Antolí, et al. · Contemporary Clinical Trials Communications · 20
PDF
Intravenous Human Plasma-Derived Augmentation Therapy in α 1 -Antitrypsin Deficiency: From Pharmacokinetic Analysis to Individualizing Therapy
2008 · Nuria Padullés Zamora, Rafael Vidal Pla, et al. · Annals of Pharmacotherapy · 19
External Evaluation of Population Pharmacokinetic Models of Infliximab in Patients With Inflammatory Bowel Disease
2017 · Eugènia Santacana, Lorena Rodríguez-Alonso, et al. · Therapeutic Drug Monitoring · 16
Methylprednisolone Pulses Plus Tacrolimus in Addition to Standard of Care vs. Standard of Care Alone in Patients With Severe COVID-19. A Randomized Controlled Trial
2021 · Xavier Solanich, Arnau Antolí, et al. · Frontiers in Medicine · 14
PDF
HLA-B*57
2016 · Cristina Ruiz-Iruela, Núria Padullés-Zamora, et al. · Pharmacogenetics and Genomics · 14
Interacción farmacocinética entre ácido valproico y meropenem
2006 · F. Sala Piñol, N. Padullés Zamora, et al. · Anales de Pediatría · 14
Predictors of Infliximab Trough Concentrations in Inflammatory Bowel Disease Patients Using a Repeated-Measures Design
2019 · Eugènia Santacana, Lorena Rodríguez-Alonso, et al. · Therapeutic Drug Monitoring · 13
Use of methoxy polyethylene glycol-epoetin beta in stage 3, 4 or 5 non-dialysis chronic kidney disease.
2012 · Núria Padullés-Zamora, Dolors Comas-Sugrañes, et al. · PubMed · 12
Pharmacokinetics of α1-Antitrypsin Replacement Therapy in Severe Congenital Emphysema
2006 · Rafael Vidal Pla, Nuria Padullés Zamora, et al. · Archivos de Bronconeumología · 12
Farmacocinética de la alfa-1-antitripsina utilizada en el tratamiento sustitutivo del enfisema congénito grave
2006 · Rafael Vidal Pla, Núria Padullés Zamora, et al. · Archivos de Bronconeumología · 11
TELEPROM Psoriasis: Enhancing patient-centered care and health-related quality of life (HRQoL) in moderate-to-severe plaque psoriasis
2024 · Gabriel Mercadal-Orfila, Piedad López Sánchez, et al. · Frontiers in Medicine · 7
PDF
[Retrospective analysis of omalizumab in patients with severe allergic asthma].
2014 · Núria Padullés Zamora, Dolors Comas Sugrañes, et al. · PubMed · 6
Long-Term Effectiveness and Safety of Proactive Therapeutic Drug Monitoring of Infliximab in Paediatric Inflammatory Bowel Disease: A Real-World Study
2024 · Susana Clemente Bautista, Óscar Segarra Cantón, et al. · Pharmaceutics · 4
PDF
Association between infliximab concentrations and clinical response in psoriasis: a prospective cohort study
2019 · M. Colls-Gonzalez, J. Notario-Rosa, et al. · Journal of Dermatological Treatment · 4
PDF
Fisiopatología del hierro.Criterios de indicación de hierro parenteral, disponibilidad y pautas de administración: revisión de la situación actual
2006 · Núria Padullés Zamora, F. Sala Piñol, et al. · Pharmaceutical care España · 4
Comparison of the EPOS 2020 and POLINA 2.0 guidelines for indicating biologic treatment in adults with chronic rhinosinusitis and nasal polyps
2025 · Mireia Golet, Núria Padullés-Zamora, et al. · Acta Otorrinolaringológica Española · 3
[Translated Article] Disease-modifying treatments for patients with multiple sclerosis in Spain
2023 · Alejandro Santiago Pérez, Santos Esteban Casado, et al. · Farmacia Hospitalaria · 3
Tratamientos modificadores de la enfermedad en pacientes con esclerosis múltiple en España
2023 · Alejandro Santiago Pérez, Santos Esteban Casado, et al. · Farmacia Hospitalaria · 3
Inhibition of SARS‐CoV‐2 replication using calcineurin inhibitors: are concentrations required clinically achievable?
2021 · X. Solanich, N. Padullés, et al. · Journal of Internal Medicine · 3
PDF
Interacción farmacocinética entre ácido valproico y meropenem
2006 · F Sala Piñol, N Padullés Zamora, et al. · Anales de Pediatría Continuada · 3
Agentes biológicos aprobados y en desarrollo clínico para el tratamiento de la dermatitis atópica
2020 · S. Otero Torres, E. Serra‐Baldrich, et al. · El Farmacéutico. Hospitales · 2
Contribution of infliximab population pharmacokinetic model for dose optimization in ulcerative colitis patients.
2016 · Eugènia Santacana Juncosa, Ariadna Padullés Zamora, et al. · PubMed · 2
Works count: 86
Citation count: 294
H-index: 12
I10-index: 13
Year
Topic
Type